Abstract
For prostate cancer as for many other solid tumors, cancer treatments are constantly and rapidly evolving. The primary goals remain, however, the same: to allow patients to live longer and to live better (1). Clinical benefit integrates, in fact, treatment effectiveness as well as assessment of quality of life (QoL).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have